Compounds studied for their influence on immune signalling and inflammatory processes.
This is a field of scientific investigation, not a category of treatment. A compound listed here has been studied in this context; that is not a claim that it treats any condition. See how we grade the evidence.
Thymosin β4 is a naturally occurring 43-amino-acid actin-binding peptide that has completed randomised human trials as an eye drop. "TB-500" is a shorter synthetic fragment sold as a research chemical — and the two are not interchangeable.
The phrase appears on nearly every research peptide sold online. It is a statement by the seller about intended use — not a regulatory designation, and not a safety assessment.
Nine questions that separate a study which tells you something from one that only looks like it does — written for readers without a research background.
A structured reading of the BPC-157 literature — how much of it there is, where it comes from, what it measured, and what the absence of published human trial results means.